Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Dec 23, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics said this week that Brian Markison has become an observer to the company's board of directors and that he will become a director at the firm upon approval. Markison currently is chairman and CEO of King Pharmaceuticals, where he led the company through to its recently announced acquisition by Pfizer, and before that he was at Bristol-Myers Squibb, where he served as president of BMS Oncology/Virology and Oncology Therapeutics Network.


Celera this week said it has tapped Alfred Merriweather to be senior vice president and CFO. Merriweather previously was executive vice president and CFO at Calypso Medical Technologies, and before that he served as CFO of Monogram Biosciences until it was bought by Laboratory Corporation of America in 2009. Merriweather also has been CFO of Symphonix Devices, Lipomatrix, and Laserscope.

Merriweather replaces Ugo DeBlasi, who left his position with the firm in November.


TcLand Expression has appointed Peter Payne to be chief business officer and head of the company's US operations. Payne most recently was VP of corporate development at Quintiles, where he also worked in senior operations and business development.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.